The Broadcaster

Possible New Treatment for Serious COVID-19 cases

Michelle Mendoza, pharmacy technician, reconstitutes the remdesivir research drug under an intravenous hood at Brooke Army Medical Center, Fort Sam Houston, Texas, April 29, 2020. The National Institute of Allergy and Infectious Diseases (NIAID)-sponsored study has enrolled hundreds of people across the nation as it looks to determine if the antiviral drug is effective against COVID-19. (U.S. Army photo by Jason W. Edwards)

Maeve Reiter, Reporter

May 6, 2020

The Lancet medical journal conducted a study between February 6 and March 12, 2020, which found that the drug Remdesivir has positive impacts on very sick COVID-19 patients. Remdesivir, described in the study by Lancet as a “nucleoside analogue prodrug,” is a drug that blocks the virus from replicating withi...

The student news site of Hershey High School
Remdesivir